JP2018501266A5 - - Google Patents

Download PDF

Info

Publication number
JP2018501266A5
JP2018501266A5 JP2017533569A JP2017533569A JP2018501266A5 JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5 JP 2017533569 A JP2017533569 A JP 2017533569A JP 2017533569 A JP2017533569 A JP 2017533569A JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
independently
optionally substituted
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533569A
Other languages
English (en)
Japanese (ja)
Other versions
JP6523461B2 (ja
JP2018501266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2015/050930 external-priority patent/WO2016102776A1/en
Publication of JP2018501266A publication Critical patent/JP2018501266A/ja
Publication of JP2018501266A5 publication Critical patent/JP2018501266A5/ja
Application granted granted Critical
Publication of JP6523461B2 publication Critical patent/JP6523461B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533569A 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ Active JP6523461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20146150 2014-12-23
FI20146150 2014-12-23
PCT/FI2015/050930 WO2016102776A1 (en) 2014-12-23 2015-12-22 Prodrugs of 17.beta.-hsd1 -inhibitors

Publications (3)

Publication Number Publication Date
JP2018501266A JP2018501266A (ja) 2018-01-18
JP2018501266A5 true JP2018501266A5 (cg-RX-API-DMAC7.html) 2019-01-17
JP6523461B2 JP6523461B2 (ja) 2019-06-05

Family

ID=55221442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533569A Active JP6523461B2 (ja) 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ

Country Status (5)

Country Link
US (1) US10413557B2 (cg-RX-API-DMAC7.html)
EP (1) EP3237431B1 (cg-RX-API-DMAC7.html)
JP (1) JP6523461B2 (cg-RX-API-DMAC7.html)
CN (1) CN107207561B (cg-RX-API-DMAC7.html)
WO (1) WO2016102776A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10626140B2 (en) * 2014-12-23 2020-04-21 Forendo Pharma Ltd Prodrugs of 17β-HSD1-inhibitors
UA126342C2 (uk) * 2017-06-08 2022-09-21 Форендо Фарма Лтд 15-бета-[3-пропанамідо]-заміщені естра-1,3,5(10)-трієн-17-он-сполуки і їх 17-оксими для використання в інгібуванні 17-бета-гідроксистероїддегідрогеназ
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof
CN120607578A (zh) * 2024-03-08 2025-09-09 长春金赛药业有限责任公司 17β-HSD1抑制剂化合物、药物组合物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1094798A2 (en) 1998-03-11 2001-05-02 Endorecherche Inc. INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
ATE355279T1 (de) 1998-08-07 2006-03-15 Novartis Vaccines & Diagnostic Pyrazole als modulatoren des östrogenrezeptors
GB9929302D0 (en) 1999-12-11 2000-02-02 Univ Cardiff Benzyl tetralins compositions and uses thereof
ATE350375T1 (de) 2001-09-06 2007-01-15 Schering Corp 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
CN1571782A (zh) 2001-10-17 2005-01-26 先灵公司 作为3型17β-羟基类固醇脱氢酶抑制剂用于治疗雄激素依赖疾病的哌啶乙酰胺类化合物和哌嗪乙酰胺类化合物
US6750248B2 (en) 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
PE20040750A1 (es) 2002-11-18 2004-11-06 Schering Corp Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3
CN1744930A (zh) 2002-12-17 2006-03-08 先灵公司 治疗雄激素依赖性疾病的3型17β-羟基类固醇脱氢酶抑制剂
WO2004085345A2 (en) 2003-03-21 2004-10-07 Yale University 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS
GB0306718D0 (en) 2003-03-24 2003-04-30 Sterix Ltd Compound
US7465739B2 (en) 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
TWI331154B (en) 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US8088758B2 (en) 2003-11-12 2012-01-03 Abbott Products Gmbh 17β-hydroxysteroid dehydrogenase type I inhibitors
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
DE102004032673A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1
DE102004032674A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US8030298B2 (en) * 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
ES2388297T3 (es) 2005-05-26 2012-10-11 Abbott Products Gmbh Inhibidores de 17-HSD1 y STS
MX2009002579A (es) 2006-09-19 2009-03-20 Solvay Pharm Gmbh Derivados de estratrieno y sus usos como inhibidores de 17beta-hidroxiesteroide deshidrogenasa.
MX2009005201A (es) * 2006-11-30 2009-05-27 Solvay Pharm Gmbh Derivados de estratrieno sustituidos como inhibidores de 17beta hsd.
BR112015031846A8 (pt) * 2013-06-25 2018-03-06 Forendo Pharma Ltd derivados de estratrientiazol, seus usos, e composição farmacêutica
US9850272B2 (en) 2013-06-25 2017-12-26 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
AR096728A1 (es) 2013-06-25 2016-01-27 Forendo Pharma Ltd Derivados de estratrieno-tiazol terapéuticamente activos
US10626140B2 (en) 2014-12-23 2020-04-21 Forendo Pharma Ltd Prodrugs of 17β-HSD1-inhibitors

Similar Documents

Publication Publication Date Title
EA201170096A1 (ru) Замещенные производные пиримидона
JP2016506958A5 (cg-RX-API-DMAC7.html)
JP2017521436A5 (cg-RX-API-DMAC7.html)
JP2017511357A5 (cg-RX-API-DMAC7.html)
JP2019104748A5 (cg-RX-API-DMAC7.html)
RU2020110780A (ru) Ингибитор fgfr и его медицинское применение
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
JP2016503799A5 (cg-RX-API-DMAC7.html)
PH12016502154A1 (en) Pyridazonine herbicides
JP2016536364A5 (cg-RX-API-DMAC7.html)
JP2016505614A5 (cg-RX-API-DMAC7.html)
EA201591429A1 (ru) 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена
TR201909694T4 (tr) Janus kinaz (jak) inhibitörleri.
EA201591703A1 (ru) Замещенные 2-азабициклы и их применение в качестве модуляторов рецепторов орексина
PH12012501773A1 (en) Arylethynyl derivatives
JP2014526533A5 (cg-RX-API-DMAC7.html)
UA117151C2 (uk) N-ациліміногетероциклічні сполуки
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
RU2021109549A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2008505194A5 (cg-RX-API-DMAC7.html)
JP2015535839A5 (cg-RX-API-DMAC7.html)
RU2020131276A (ru) Терапевтические соединения и композиции
JP2014510147A5 (cg-RX-API-DMAC7.html)
JP2015530408A5 (cg-RX-API-DMAC7.html)